Menu
NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
7475 Lusk Blvd
San Diego, California 92121-5707
Phone: 18589091800
www.nuvasive.com
… completion of their previously announced merger . The news sent GMED shares … discuss the closing of the merger and its potential benefits … David Paul said. “I’ m incredibly proud of the strong … surgeon customers and their patients as a combined company.” In …
Planned changes to the S&P SmallCap 600 include Jackson Financial (JXN) replacing NexTier Oilfield Solutions (NEX) and Goosehead Insurance (GSHD) replacing NuVasive (NUVA), S&P Dow…
NuVasive (NUVA) rose 3% amid a Nasdaq delisting notice for its planned sale to Globus Medical (GMED)
#NuVasive #reports #increased #net #sales #secondquarter #financial #results NuVasive Inc. has reported increased net sales for the second quarter of 2023, citing the adoption of new products and increased procedural volumes as driving factors. The company announced net sales of $317.8 million, a 2.4% increase compared to the previous year. In addition, NuVasive reported a …
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ETCompany ParticipantsJuliet Cunningham – Vice President-Investor RelationsChris Barry – Chief…
WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: $7.36 million in Q2 vs. -$0.89 million in the same period last year. EPS: $0.14 in Q2 vs. -$0.02 in the…
NuVasive press release (NUVA): Q2 Non-GAAP EPS of $0.56 beats by $0.01.Revenue of $317.8M (+2.4% Y/Y) misses by $5.32M.For the second quarter of 2023, GAAP and non-GAAP gross profit…
NuVasive (NASDAQ: NUVA ) is set to give its latest quarterly earnings report on Wednesday, 2023-08-02. Here''s what investors need to know before the announcement. Analysts estimate that NuVasive will report an earnings per share (EPS) of $0.56. NuVasive bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com
Texas Permanent School Fund Corp Boosts Holding in NuVasive, Inc. Date: July 31, 2023 In a surprising move that has left industry experts bewildered, the Texas Permanent School Fund Corp has recently announced a substantial increase in its holdings of shares in NuVasive, Inc. This unexpected development occurred during the first quarter of the year, […] The post Texas Permanent School Fund Corp Makes Bold Investment in NuVasive, Inc.: A Statement of Confidence in the Medical Device Company’s Future appeared first on Best Stocks .
Texas Permanent School Fund Corp raised its position in NuVasive, Inc. (NASDAQ:NUVA – Free Report) by 35.0% during the first quarter, HoldingsChannel reports. The firm owned 46,754 shares of the medical device company’s stock after buying an additional 12,133 shares during the quarter. Texas Permanent School Fund Corp’s holdings in NuVasive were worth $1,931,000 as […]